Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heffner

Showing results (911-920 of 1,030) with videos related to

Pageof 103
Sort By:
Blood|September 10, 2014
Long-term follow-up from a phase 1/2 study of single-agent bortezomib in relapsed systemic AL amyloidosisDonna E Reece, Ute Hegenbart, Vaishali Sanchorawala, et al.
Blood|November 19, 2020
Final results of a phase 1 study of loncastuximab tesirine in relapsed/refractory B-cell non-Hodgkin lymphomaMehdi Hamadani, John Radford, Carmelo Carlo-Stella, et al.
Respirology (Carlton, Vic.)|February 12, 2009
Road ahead to respiratory health: experts chart future research directionsJohn E Heffner, Stephen T Holgate, Kian Fan Chung, et al.
British Journal of Haematology|August 8, 2015
A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non-Hodgkin's lymphomaJonathon B Cohen, Jeffrey M Switchenko, Jean L Koff, et al.
Bone Marrow Transplantation|August 1, 1997
Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiationR B Geller, S M Devine, K O'Toole, et al.
Biotechnology and Bioengineering|April 29, 2018
A reference genome of the Chinese hamster based on a hybrid assembly strategyOliver Rupp, Madolyn L MacDonald, Shangzhong Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2012
Signaling axis involving Hedgehog, Notch, and Scl promotes the embryonic endothelial-to-hematopoietic transitionPeter Geon Kim, Colleen E Albacker, Yi-fen Lu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 6, 2017
Prostaglandin E<sub>2</sub> Increases Lentiviral Vector Transduction Efficiency of Adult Human Hematopoietic Stem and Progenitor CellsGarrett C Heffner, Melissa Bonner, Lauryn Christiansen, et al.
Blood Cancer Journal|November 27, 2019
Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasoneTimothy M Schmidt, Benjamin G Barwick, Nisha Joseph, et al.
Journal of the American Geriatrics Society|June 30, 2026
Stakeholder Perspectives on the Use of Telehealth to Support Deprescribing for Older Patients Transitioning From the Hospital to Home Health CareJinjiao Wang, Jenny Y Shen, Fang Yu, et al.
Pageof 103

Showing results (911-920 of 1,030) with videos related to

Sort By:
Pageof 103
Blood|September 10, 2014
Long-term follow-up from a phase 1/2 study of single-agent bortezomib in relapsed systemic AL amyloidosisDonna E Reece, Ute Hegenbart, Vaishali Sanchorawala, et al.
Blood|November 19, 2020
Final results of a phase 1 study of loncastuximab tesirine in relapsed/refractory B-cell non-Hodgkin lymphomaMehdi Hamadani, John Radford, Carmelo Carlo-Stella, et al.
Respirology (Carlton, Vic.)|February 12, 2009
Road ahead to respiratory health: experts chart future research directionsJohn E Heffner, Stephen T Holgate, Kian Fan Chung, et al.
British Journal of Haematology|August 8, 2015
A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non-Hodgkin's lymphomaJonathon B Cohen, Jeffrey M Switchenko, Jean L Koff, et al.
Bone Marrow Transplantation|August 1, 1997
Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiationR B Geller, S M Devine, K O'Toole, et al.
Biotechnology and Bioengineering|April 29, 2018
A reference genome of the Chinese hamster based on a hybrid assembly strategyOliver Rupp, Madolyn L MacDonald, Shangzhong Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2012
Signaling axis involving Hedgehog, Notch, and Scl promotes the embryonic endothelial-to-hematopoietic transitionPeter Geon Kim, Colleen E Albacker, Yi-fen Lu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 6, 2017
Prostaglandin E<sub>2</sub> Increases Lentiviral Vector Transduction Efficiency of Adult Human Hematopoietic Stem and Progenitor CellsGarrett C Heffner, Melissa Bonner, Lauryn Christiansen, et al.
Blood Cancer Journal|November 27, 2019
Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasoneTimothy M Schmidt, Benjamin G Barwick, Nisha Joseph, et al.
Journal of the American Geriatrics Society|June 30, 2026
Stakeholder Perspectives on the Use of Telehealth to Support Deprescribing for Older Patients Transitioning From the Hospital to Home Health CareJinjiao Wang, Jenny Y Shen, Fang Yu, et al.
Pageof 103